Ndio maana wa akina Msekwa,Malecela na Mwinyi hawawezi kuiachia SISIEM.Dou believe kama Jacob Msekwa atakuwa ubalozi Sweden bila ya baba yake kupeta?Je Hussein Mwinyi waziri wa Ulinzi?Je Dr Mwele Malecela nafasi yake Utafiti?
Nchi yetu elitism ni kubwa sasa,ndani ya makucha ya SISIEM.Mbali zaidi hawa wanachaguliwa na illiterates huko vijijini!
- Mkuu muogope Mungu wako japo kidogo, CCM haiwezi kumpachika mtoto wa mtu yoyote Tanzania awe masikini au kigogo, katika mavitu mazito ya dunia kama hili hapa chini, Great Thinkers tunapaswa kua better than hizi longo longo bila facts!
Respect.
FMEs!
EXECUTIVE GROUP
The mission of the Executive Group (EG) is "to support the Global Programme by enhancing the effectiveness of national, regional and global fundraising, advocacy, communication and planning for the Programme."
Following are short biographies for the five elected EG members, the RCG Chair (ex-officio member of the EG), the two co-opted country representatives and the three observers.
ELECTED MEMBERS
Adrian HOPKINS
Elected member
Contact: ahopkins@taskforce.org
Dr. Hopkins who hails from England completed his medical training in Scotland in 1971 and four years later, after surgical and other training, including the DTM&H at Liverpool, he moved to what was then Zaire to work in a rural Baptist Mission Hospital in an area of tropical rain forest called Pimu. Pimu was once described by a group of visiting public health specialists as "too rural for rural health care." He remained there for most of 17 years with some brief spells in Kimpese and Yakusu in Zaire and some time in England to complete his Diploma in Ophthalmology.
In 1993, Dr. Hopkins became technical advisor to the Central African Republic Ministry of Health for the National Programme for Onchocerciasis Control and Prevention of Blindness, working with the Christoffel-Blindenmission (CBM). In 1999, in spite of the ongoing civil war, he returned to the Congo, to Kinshasa, to establish the Training Centre for Ophthalmology for Central Africa (CFOAC), which is a centre for training mid-level personnel in eye care. For twelve years from 1995 he was Medical Advisor for CBM for the Central African Region and has also been their advisor for onchocerciasis control which involved continuous oversight of programs in CAR, DRC, Sudan and Burundi. The latter program is now being transformed into a Program for Control of Neglected Tropical Diseases.
Dr. Hopkins also served for four years on the Technical Consultative Committee of APOC and completed four years as chairperson of the NGDO coordination group for onchocerciasis control and has been involved in the NGDO LF Network and the Africa Region RPRG for LF. He has also been very involved in national planning and implementation of the WHO/IAPB Vision 2020 program to eliminate avoidable blindness, mostly in French-speaking regions of Africa.
In January 2008 Dr Hopkins was appointed as Director for the Mectizan Donation Program (MDP), located at the Task Force for Child Survival and Development in Decatur, Georgia (USA).
Patrick LAMMIE
Elected member
Contact: pjl1@cdc.gov
Pat Lammie is the Team Leader of the Diseases Elimination and Control Group in the Division of Parasitic Diseases at the Centers for Disease Control and Prevention (CDC). Pat received his PhD from Tulane University in 1983 following doctoral research on the immunology of experimental filariasis. After a post-doctoral fellowship at the University of Pennsylvania, he worked at LSU Medical Center in New Orleans before moving to CDC. Pat's current research is focused primarily on lymphatic filariasis. His lab is heavily invested in efforts to develop new tools and strategies to monitor and evaluate the Global Programme to Eliminate Lymphatic Filariasis.
Bernhard LIESE
Elected member
Contact: b.liese@worldbank.org
Bernhard H. Liese, a German national, is currently Chair, International Health Department, Georgetown University School of Nursing & Health Studies (NHS). He is also Public Health Advisor/Consultant to the World Bank's Africa Region. Before joining Georgetown University in 2002, Bernhard worked for the World Bank. He joined the Bank in 1976 as Public Health Specialist in the Office of the Vice-President, Projects; subsequently, he worked in various functions in establishing Health Lending at the Bank as Senior Public Health Professional on Tropical Diseases and HIV/AIDS and as Manager in the newly established Population, Health & Nutrition Department.
For nearly a decade Bernhard was responsible for the Joint Bank/IMF Health Services Department. While Director of HSD, he also was the Bank representative for some of the large multi-donor global health programs which the Bank co-sponsors, eg the Special Program for Training and Research in Tropical Diseases (TDR), and the African Programs for Riverblindness Control (OCP and APOC). Most recently, he was Senior Advisor, Human Development Department, Africa Region.
David MOLYNEUX PhD, DSc, Hon, FRCP
Chair (elected member)
Contact: david.molyneux@liv.ac.uk
David Molyneux was Director of the Liverpool School of Tropical Medicine (LSTM) Lymphatic Filariasis Support Centre (LFSC) since its launch in April 2000 until his semi-retirement in April 2008. The Centre (which has been renamed to recognise its expanded activities as the Neglected Tropical Disease Control Centre – incorporating the LFSC) is supported by the Department for International Development (DFID) and GlaxoSmithKline (GSK). Continuing at the School as a Senior Professorial Fellow David will continue to utilise his extensive knowledge of parasitic disease control to offer technical support and advice to the Global Programme to Eliminate Lymphatic Filariasis
Prior to his directorship of the Centre David was the Director of the Liverpool School of Tropical Medicine (1991-2000). From 1977-91 he was successively Professor of Biology, Chairman of the Department of Biological Sciences and Dean of Science at the University of Salford. David graduated (MA, PhD) from Cambridge University in parasitology before embarking on a career in medical parasitology and parasitology. His research was awarded a DSc from the University of Salford. His early research interests were trypanosomiasis and leishmaniasis. He is a member of the WHO Panel of Experts on Parasitic Diseases, the International Task Force for Disease Eradication of the Carter Center, the WHO International Commission for the Eradication of Dracunculus (Guinea Worm) and WHO's Strategic Technical Advisory Group (STAG) for Neglected Tropical Disease (NTD).
David has travelled extensively in Africa as well as the Middle East and Latin America working with, and addressing, various programmes. He has published over 300 papers in learned biomedical science journals, written over 20 reviews and contributions to books as well as a textbook on trypanosomes and leishmania and edited a major text on the Control of Human Parasitic Diseases published in June 2006. He has acted as a consultant to several organisations including WHO, FAO, UNDP, the World Bank and the UK government (DFID). David's current interests are in health policy around the integration of Neglected Tropical Diseases and the implementation of large scale programmes based on annual preventative chemotherapy.
Mwele Ntuli MALECELABsc, Msc, PhD
Chair, Representative Contact Group (ex-officio member)
Contact: mmalecela@hotmail.com
Dr Malecela is Director of the Tanzania Lymphatic Filariasis Elimination Programmme, as well as Director of Research Coordination and Promotion of the National Institute for Medical Research (NIMR) Tanzania.
Mwele holds a Bsc in Zoology from the University of Dar-es-salaam and an MSc and PhD in Parasitology from the University of London (London School of Hygiene and Tropical Medicine). Her area of specialization was the immunology of filarial evasion mechanisms.
Mwele has worked at the National institute for Medical Research for over 20 years in a number of areas including Lymphatic Filariasis immune epidemiology, and health systems and policies. As Director for Research at NIMR, her main focus is on research capacity building, the translation of research into action, as well as the policy and practice of priority setting for health research.
In her role as Director of the National Lymphatic Filariasis Elimination Programme she brings her long research experience to efforts to eliminate filariasis, and she has run the national programme since its inception in 2000. She is well known for her role in advocacy campaigns that have raised the profile of the real extent of the problem in Tanzania.
Mwele has served on a number of international committees including the Technical Advisory Group of the Global Programme to Eliminate Lymphatic Filariasis, the Mectizan Expert Committee and the advisory board of the Initiative on Public-Private Partnerships in Health (IPPPH).
Mwele is the Chair of the Representative Contact Group (RCG), a position which has ex-officio membership on the Executive Group. Mwele was initially elected to the Chair at the Fiji meeting in 2006 and was unanimously re-elected at the Tanzania, Arusha meeting in 2008.
CP RAMACHANDRAN
Elected member
Contact: ramacp@hotmail.com
Professor Dato Dr. CP Ramachandran undertook his graduate and postgraduate studies at the Universities of Madras, London, Liverpool, Tulane and Tokyo. Starting as a lecturer at the Faculty of Medicine University Malaya in 1963, he moved on in l967 to become theChief of Filariasis Research and Control at theInstitute for Medical Research in Kuala Lumpur. In 1970 he joined Universiti Sains Malaysia (USM) as Professor of Medical Parasitology and Dean of the School of Biological Sciences, where he helped to develop undergraduate and postgraduate programmes and sent many young Malaysians abroad foracademic and research training.
In 1979, on secondment from USM, CP moved to Geneva to join the WHO Tropical Disease Research and Control of Tropical Diseases Programmes as Chief of Filariasis Research and Control. In this dual capacity he focused the attention of the global scientific community on the magnitude of the disease burden and the problem of filariasis, especially among the poorest of the poor. He was instrumental in initiating newer chemotherapeutic clinical trials for the control of onchocerciasis and lymphatic filariasis and introduced ivermectin and albendazole as new anti-filarial drugs in combination with diethylcarbamazine to the therapeutic armamentarium.
While in WHO, he was also responsible for postgraduate training of young scientists from developing countries in tropical diseases research and for the establishment of centres of excellence in tropical disease research in many of the developing countries. After retiring from WHO in 1996, he wasappointed as Professor of Medical Parasitology at the newly established Faculty of Medicine, Universiti Putra Malaysia.
CP is a recipient of a number of awards recognizing his contribution to tropical medicine including the Sandosham Gold Medal for Tropical Medicine, the Mary Kingsley Medal from the Liverpool School of Tropical Medicine and National/State Awards of JSM and DSPN.
He is a Fellow of the London Institute of Biology, the Academy of Medicine of Malaysia and the Academy of Sciences, Malaysia and the Australasian College of Tropical Medicine. He is also an Honorary Fellow of the UK Royal Society of Tropical Medicine & Hygiene and the Liverpool School of Tropical Medicine and Honorary Professor of the Faculty of Tropical Medicine, Prince Mahidol University, Bangkok. He is a founder member and past President of the Malaysian Society of Parasitology and Tropical Medicine
Whilst at WHO CP was instrumental in initiating the Global Programme to Eliminate Lymphatic Filariasis (GPELF) and until recently he chaired the Technical Advisory Group (TAG). Today he continues as a consultant on lymphatic Filariasis and as Chair of Mekong Plus Regional Programme Review Group.
CO-OPTED COUNTRY REPRESENTATIVES
Tilaka LIYANAGE
Contact: dashi@sltnet.lk
Dr.Tilaka Savitri Liyanage is the present Director of the Anti-Filariasis Campaign in Sri Lanka. A Senior Medical Administrator in the Ministry of Health, Sri Lanka she has a broad in-depth knowledge and experience of lymphatic filariasis control. Prior to her current appointment in 2001, she worked as a Regional Medical Officer of the Anti-Filariasis Campaign for thirteen years.
Tilaka received her MBBS degree from the University of Colombo in1978 and MSc in Community Medicine from the Post Graduate Institute of Medicine, Colombo. She undertook postgraduate training in Tropical Health at the University of Queensland in Australia where she obtained her Master of Tropical Health in 1992/93.
She gained a wider experience in preventive and promotive health care services for maternal and child health, communicable diseases and non-communicable diseases when she worked as a Medical Officer of Health for ten years. She continues to be involved in the training of primary health care workers, public health physicians, medical administrators and as a part-time lecturer for undergraduate medical students.
Tilaka led the National Mass Drug Administration Programme for five consecutive years from 2002-2006.
From 2006-7 Tilaka served as a member of the WHO Technical Advisory Group of the Global Programme to Eliminate Lymphatic Filariasis.
Dominique KYELEM MD, MSc, PhD
Contact: dkyelem@taskforce.org and
dominiquekyelem@yahoo.fr
Dr. Dominique Kyelem is Project Manager at the US (Atlanta) Lymphatic Filariasis Support Center (LFSC). He serves as a key liaison of the LF Support Center to various partner organizations and is responsible for developing and implementing various program objectives of the Gates grant to the GAELF entitled: "Resolving the Critical Challenges Now Facing the Global Programme to Eliminate Lymphatic Filariasis".
Dr Kyelem was a GP for several years before embracing the public health field. He performed ultrasonography and hydrocelectomy while in the regional hospital of Dori, in northern Burkina, where he was Director of the hospital. His public health career started with his appointment as Director of Health of the Northern Region in Burkina Faso.
Prior to joining the Atlanta LFSC in 2007, Dr Kyelem was in charge of the unit of communicable diseases including lymphatic filariasis in the Ministry of Health of Burkina Faso; he worked at various levels and sectors of the health system of his country for more than 14 years. In 1996, his hospital received the label "Baby friendly hospital" for its good breastfeeding practice; he was the pioneer of national NIDs for polio eradication district level implementation in Burkina Faso. Dr Kyelem has been a consultant for WHO since 2001 supporting African countries in lymphatic filariasis elimination activities and is a member of several advisory committees. He extensively worked on Guinea worm and initiated the Schistosomiasis Control Programme in Burkina Faso in October 1999 as the first its Programme Manager.
Dr. Kyelem holds a medical degree from the University of Ouagadougou (Burkina Faso), a Masters in Public Health degree from the University of Heidelberg (Germany) and a PhD degree from the University of Liverpool (United Kingdom). He speaks French and English.
OBSERVERS
GLAXOSMITHKLINE - Andy Wright MBA
Contact: andy.l.wright@gsk.com
Andy Wright has a Bachelors degree in Civil Engineering and a Masters degree in Project Management. He is a Chartered Engineer whose early career includes project management of capital projects within the petrochemical construction industry, roles in marketing and business development and project management consultancy.
In 1994, Andy joined GlaxoSmithKline (GSK), working on global supply chain programmes and IT projects. Since 2000, he has been active in the global campaign to eliminate lymphatic filariasis. GSK is a key partner in the global effort, donating albendazole, one of two drugs required, for every country that needs it until the disease is eliminated. Andy is currently the Director of the LF Programme, which is GSK's flagship health initiative within its Global Community Partnerships Department.
MERCK & CO. INC. – Ken Gustavsen BSc
Contact: ken_gustavsen@merck.com
Ken Gustavsen is Manager, Global Product Donations for Merck & Co. Inc. His responsibilities include the management and strategic development of all activities associated with the Merck Mectizan® Donation Program. He serves as the liaison between Merck and its partners involved in Mectizan® distribution for onchocerciasis (river blindness) and lymphatic filariasis. He also manages Merck's donations of other pharmaceutical products and vaccines. Ken has been with Merck since October 2000. Prior to joining Merck he worked for the non-profit organization World Relief, where he served
as Project Director in Kosovo (Yugoslavia). There he directed World Relief's post-war activities and coordinated efforts with the United Nations, NATO, USAID and other government and non-governmental agencies.
Before his work with World Relief, Ken was a Lieutenant in the United States Navy. Ken graduated from the United States Naval Academy with a Bachelor of Science degree in oceanography and is currently working towards a Master of Business Administration degree at Rutgers University.
WORLD HEALTH ORGANIZATION - Contact: neglected.diseases@who.int